Pharmacokinetics and safety of LEAD-452, an EGFR-specific 4-1BB-agonistic trimerbody in non-human primates.
- DOI
- 10.1016/j.taap.2024.116961
- Published
- 2024 Jun
- Container
- Toxicology and applied pharmacology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.taap.2024.116961,
title = {Pharmacokinetics and safety of LEAD-452, an EGFR-specific 4-1BB-agonistic trimerbody in non-human primates.},
author = {Navarro R and Frago S and Hangiu O and Erce-Llamazares A and Lázaro-Gorines R and Morcillo MA and Rodriguez-Peralto JL and Sanz L and Compte M and Alvarez-Vallina L},
year = {2024},
journal = {Toxicology and applied pharmacology},
doi = {10.1016/j.taap.2024.116961},
url = {https://doi.org/10.1016/j.taap.2024.116961}
}RIS
TY - JOUR TI - Pharmacokinetics and safety of LEAD-452, an EGFR-specific 4-1BB-agonistic trimerbody in non-human primates. AU - Navarro R AU - Frago S AU - Hangiu O AU - Erce-Llamazares A AU - Lázaro-Gorines R AU - Morcillo MA AU - Rodriguez-Peralto JL AU - Sanz L AU - Compte M AU - Alvarez-Vallina L PY - 2024 JO - Toxicology and applied pharmacology DO - 10.1016/j.taap.2024.116961 UR - https://doi.org/10.1016/j.taap.2024.116961 ER -
APA
R, N., S, F., O, H., A, E., R, L., MA, M., JL, R., L, S., M, C., & L, A. (2024). Pharmacokinetics and safety of LEAD-452, an EGFR-specific 4-1BB-agonistic trimerbody in non-human primates.. Toxicology and applied pharmacology. https://doi.org/10.1016/j.taap.2024.116961
Source records
- pubmed · retrieved 2026-09-27T10:50:13.903Z